• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The comparative efficacy of naproxen sodium and pirprofen in the treatment of post-operative pain.

作者信息

Baumgartner H, Kuttelwascher M, McCaskey D, Winters L

出版信息

J Int Med Res. 1987 May-Jun;15(3):179-87. doi: 10.1177/030006058701500309.

DOI:10.1177/030006058701500309
PMID:3301458
Abstract

A randomized, single-blind, parallel study involving 100 adults was performed to compare the efficacy and safety of naproxen sodium with that of pirprofen in the treatment of moderate to severe pain after orthopaedic surgery. Fifty patients received 550 mg of naproxen sodium initially and 275 mg every 6 h thereafter, and 50 received 400 mg of pirprofen every 8 h until either their pain was completely relieved or the 3-day trial ended. Patients who required additional analgesia were given 500 mg of paracetamol 2 h after administration of the test medication. Both medications significantly relieved post-operative pain, and there were no statistically significant differences in efficacy between the groups. Six patients receiving naproxen sodium and two patients receiving pirprofen withdrew from the study because of lack of efficacy. Thirteen patients receiving naproxen sodium recorded 17 adverse events and 13 patients receiving pirprofen recorded 20 adverse events, again with no statistically significant differences between groups. Six patients in each group withdrew from the study because of these adverse events. Naproxen sodium and pirprofen were equally safe and effective in relieving post-operative pain following musculoskeletal surgery.

摘要

相似文献

1
The comparative efficacy of naproxen sodium and pirprofen in the treatment of post-operative pain.
J Int Med Res. 1987 May-Jun;15(3):179-87. doi: 10.1177/030006058701500309.
2
Efficacy and tolerance of naproxen versus pirprofen in the treatment of patients with osteoarthritis.
Pharmatherapeutica. 1987;5(1):16-20.
3
Pirprofen, naproxen and placebo in the treatment of primary dysmenorrhoea.
Drugs Exp Clin Res. 1987;13(11):699-705.
4
A comparison of severe gastric damage as a result of pirprofen and naproxen treatment in rheumatoid arthritis: a controlled endoscopic study.吡洛芬与萘普生治疗类风湿关节炎所致严重胃损伤的比较:一项内镜对照研究。
J Intern Med. 1994 Aug;236(2):153-9. doi: 10.1111/j.1365-2796.1994.tb01277.x.
5
The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium.吡罗昔康(FDDF)和萘普生钠的术后镇痛效果及安全性。
Int J Clin Pharmacol Res. 1998;18(1):21-9.
6
[Comparative study between pirprofen (Rengasil) and piritramid (Dipidolar) in postoperative pain in maxillofacial surgery].[吡洛芬(Rengasil)与匹立米洞(Dipidolar)用于颌面外科手术后疼痛的比较研究]
Acta Stomatol Belg. 1989 Dec;86(4):259-63.
7
[Comparative study between pirprofen (Rengasil) and piritramid (Dipidolor) for postoperative pain in maxillofacial surgery].吡洛芬(Rengasil)与匹立米洞(Dipidolor)用于颌面外科手术后疼痛的比较研究
Acta Stomatol Belg. 1989 Dec;86(4):259-63.
8
[Clinical trials with pirprofen and naproxen in patients with gonarthrosis and coxarthrosis].
Fortschr Med. 1985 Feb 26;103(SPEC NO 7A):182-4.
9
[A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis].一种新型非甾体抗炎药吡洛芬(rengasil)治疗类风湿关节炎和骨关节炎
Ter Arkh. 1987;59(4):73-6.
10
Comparison of the efficacy of naproxen sodium and dihydrocodeine tartrate in the treatment of post-operative pain.萘普生钠与酒石酸二氢可待因治疗术后疼痛的疗效比较。
Curr Med Res Opin. 1988;10(10):656-62. doi: 10.1185/03007998809111115.

引用本文的文献

1
Single dose oral naproxen and naproxen sodium for acute postoperative pain.单剂量口服萘普生和萘普生钠用于术后急性疼痛。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD004234. doi: 10.1002/14651858.CD004234.pub2.
2
Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.萘普生。对其药理学以及在风湿性疾病和疼痛状态中的治疗用途的重新评估。
Drugs. 1990 Jul;40(1):91-137. doi: 10.2165/00003495-199040010-00006.